ALPHATEC HOLDINGS, INC. Compensation Expense, Excluding Cost of Good and Service Sold
ALPHATEC HOLDINGS, INC. (ATEC) reported Compensation Expense, Excluding Cost of Good and Service Sold of $900.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold · last filed 2022-03-02
- ALPHATEC HOLDINGS, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2020-12-31 was $0.00.
- ALPHATEC HOLDINGS, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2020-09-30 was $100.00K.
- ALPHATEC HOLDINGS, INC. compensation expense, excluding cost of good and service sold for fiscal 2020 was $900.00K.
| Period end | Compensation Expense, Excluding Cost of Good and Service Sold 3 month | Compensation Expense, Excluding Cost of Good and Service Sold 6 month | Compensation Expense, Excluding Cost of Good and Service Sold 9 month | Compensation Expense, Excluding Cost of Good and Service Sold 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $100.00K derived: sum of 2 quarters · filed 2022-03-02 | $900.00K 10-K · filed 2022-03-02 | |
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-05 | $900.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |